Published: 26 Aug 2020 | Report Code: 10247661 | Pages: 199
Global digital biomarkers market will reach $22.54 billion by 2030, growing by 36.2% annually over 2020-2030 driven by rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare. Highlighted with 91 tables and 99 figures, this 199-page report “Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Region. Based on System Component, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Data Collection Tools • Digital Platforms • Mobile Apps • Desktop-based Software • Wearables • Biosensors Data Integration Systems Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Cardiovascular Diseases Neurodegenerative Disorders • Parkinson’s Disease • Multiple Sclerosis • Alzheimer’s Disease Sleep and Movement Diseases Psychiatric Disorders Chronic Pain Gastrointestinal Diseases Diabetes Respiratory Conditions Other Diseases Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Wellness • Disease Diagnosis • Personalised Medication • Drug Discovery and Development Based on Development Status, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Novel Digital Biomarkers • Original Digital Biomarkers • Approved Digital Biomarkers Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Biopharmaceutical Companies & Labs • Healthcare Providers • Insurance Payers Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, The Netherlands, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Spain, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, Israel) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by System Component, Therapeutic Area, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global digital biomarkers market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Actigraph LLC Akili Interactive Labs AliveCor Inc Altoida Inc Amgen Inc Bayer AG Biogen Inc Cambridge Cognition Plc Eli Lilly and Company Evidation Health, Inc. F. Hoffmann-La Roche Ltd Fitbit Inc GlaxoSmithKline Plc Happify Health Human API IXICO Plc Koninklijke Philips N.V. Medical Care Corporation Medopad Ltd Mindstrong Health Neurotrack Technology, Inc Novartis International AG Pfizer Inc. Quanterix Corporation Sanofi S.A. The Takeda Pharmaceuticals Company Limited Verily Life Sciences Winterlight Labs Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table Of Contents
1 Introduction 10 1.1 Industry Definition and Research Scope 10 1.1.1 Industry Definition 10 1.1.2 Research Scope 11 1.2 Research Methodology 14 1.2.1 Overview of Market Research Methodology 14 1.2.2 Market Assumption 15 1.2.3 Secondary Data 15 1.2.4 Primary Data 15 1.2.5 Data Filtration and Model Design 17 1.2.6 Market Size/Share Estimation 18 1.2.7 Research Limitations 19 1.3 Executive Summary 20 2 Market Overview and Dynamics 23 2.1 Market Size and Forecast 23 2.1.1 Impact of COVID-19 on the Market 28 2.2 Major Growth Drivers 30 2.3 Market Restraints and Challenges 35 2.4 Emerging Opportunities and Market Trends 40 2.5 Porter’s Fiver Forces Analysis 44 3 Segmentation of Global Market by System Component 48 3.1 Market Overview by System Component 48 3.2 Data Collection Tools 50 3.2.1 Digital Platforms 52 3.2.2 Mobile Apps 53 3.2.3 Desktop-based Software 54 3.2.4 Wearables 55 3.2.5 Biosensors 56 3.3 Data Integration Systems 57 4 Segmentation of Global Market by Therapeutic Area 58 4.1 Market Overview by Therapeutic Area 58 4.2 Cardiovascular Diseases 60 4.3 Neurodegenerative Disorders 61 4.3.1 Parkinson’s Disease 63 4.3.2 Multiple Sclerosis 64 4.3.3 Alzheimer’s Disease 65 4.4 Sleep and Movement Diseases 66 4.5 Psychiatric Disorders 67 4.6 Chronic Pain 68 4.7 Gastrointestinal Diseases 69 4.8 Diabetes 70 4.9 Respiratory Conditions 71 4.10 Other Diseases 72 5 Segmentation of Global Market by Application 73 5.1 Market Overview by Application 73 5.2 Wellness 75 5.3 Disease Diagnosis 76 5.4 Personalised Medication 77 5.5 Drug Discovery and Development 78 6 Segmentation of Global Market by Development Status 80 6.1 Market Overview by Development Status 80 6.2 Novel Digital Biomarkers 83 6.3 Original Digital Biomarkers 84 6.4 Approved Digital Biomarkers 85 7 Segmentation of Global Market by End User 86 7.1 Market Overview by End User 86 7.2 Biopharmaceutical Companies & Labs 88 7.3 Healthcare Providers 89 7.4 Insurance Payers 90 8 Segmentation of Global Market by Region 91 8.1 Geographic Market Overview 2019-2030 91 8.2 North America Market 2019-2030 by Country 95 8.2.1 Overview of North America Market 95 8.2.2 U.S. 99 8.2.3 Canada 103 8.2.4 Mexico 105 8.3 European Market 2019-2030 by Country 107 8.3.1 Overview of European Market 107 8.3.2 Germany 111 8.3.3 UK 113 8.3.4 France 115 8.3.5 Netherlands 117 8.3.6 Italy 119 8.3.7 Russia 121 8.3.8 Rest of European Market 123 8.4 Asia-Pacific Market 2019-2030 by Country 125 8.4.1 Overview of Asia-Pacific Market 125 8.4.2 Japan 129 8.4.3 China 132 8.4.4 Australia 134 8.4.5 India 136 8.4.6 South Korea 138 8.4.7 Rest of APAC Region 140 8.5 South America Market 2019-2030 by Country 142 8.5.1 Argentina 145 8.5.2 Brazil 147 8.5.3 Chile 149 8.5.4 Rest of South America Market 151 8.6 MEA Market 2019-2030 by Country 152 8.6.1 UAE 155 8.6.2 Saudi Arabia 157 8.6.3 Israel 159 8.6.4 Other National Markets 161 9 Competitive Landscape 162 9.1 Overview of Key Vendors 162 9.2 New Product Launch, Partnership, Investment, and M&A 166 9.3 Company Profiles 167 Actigraph LLC 167 Akili Interactive Labs 169 AliveCor Inc 170 Altoida Inc 171 Amgen Inc 172 Bayer AG 173 Biogen Inc 174 Cambridge Cognition Plc 175 Eli Lilly and Company 176 Evidation Health, Inc. 177 F. Hoffmann-La Roche Ltd 178 Fitbit Inc 179 GlaxoSmithKline Plc 180 Happify Health 181 Human API 182 IXICO Plc 183 Koninklijke Philips N.V. 184 Medical Care Corporation 185 Medopad Ltd 186 Mindstrong Health 187 Neurotrack Technology, Inc 188 Novartis International AG 189 Pfizer Inc. 190 Quanterix Corporation 191 Sanofi S.A. 192 The Takeda Pharmaceuticals Company Limited 193 Verily Life Sciences 194 Winterlight Labs Inc. 195 10 Investing in Global Market: Risk Assessment and Management 196 10.1 Risk Evaluation of Global Market 196 10.2 Critical Success Factors (CSFs) 199 Related Reports and Products 199
List Of Tables
Table 1. Snapshot of Global Digital Biomarkers Market, 2019-2030 21 Table 2. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples 25 Table 3. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets, 2019-2030 33 Table 4. World Mobile Data Traffic by Deployment Mode, 2019-2030, EB/year 34 Table 5. World Mobile Data Traffic by Device, 2019-2030, EB/year 34 Table 6. Current Challenges of Digital Biomarkers in Medical Settings 37 Table 7. Main Product Trends and Market Opportunities in Global Digital Biomarkers Market 40 Table 8. Global Digital Biomarkers Market by System Component, 2019-2030, $ mn 48 Table 9. Global Digital Biomarkers Market: Data Collection Tools by Type, 2019-2030, $ mn 51 Table 10. Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 58 Table 11. Global Digital Biomarkers Market: Neurodegenerative Disorders by Type, 2019-2030, $ mn 62 Table 12. Global Digital Biomarkers Market by Application, 2019-2030, $ mn 73 Table 13. Global Digital Biomarkers Market by Development Status, 2019-2030, $ mn 81 Table 14. Global Digital Biomarkers Market by End User, 2019-2030, $ mn 86 Table 15. Global Digital Biomarkers Market by Region, 2019-2030, $ mn 92 Table 16. Leading National Digital Biomarkers Market, 2019 and 2030, $ mn 94 Table 17. North America Digital Biomarkers Market by Country, 2019-2030, $ mn 97 Table 18. U.S. Digital Biomarkers Market by System Component, 2019-2030, $ mn 101 Table 19. U.S. Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 101 Table 20. U.S. Digital Biomarkers Market by End User, 2019-2030, $ mn 101 Table 21. Canada Digital Biomarkers Market by System Component, 2019-2030, $ mn 104 Table 22. Canada Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 104 Table 23. Canada Digital Biomarkers Market by End User, 2019-2030, $ mn 104 Table 24. Mexico Digital Biomarkers Market by System Component, 2019-2030, $ mn 106 Table 25. Mexico Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 106 Table 26. Mexico Digital Biomarkers Market by End User, 2019-2030, $ mn 106 Table 27. Europe Digital Biomarkers Market by Country, 2019-2030, $ mn 110 Table 28. Germany Digital Biomarkers Market by System Component, 2019-2030, $ mn 112 Table 29. Germany Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 112 Table 30. Germany Digital Biomarkers Market by End User, 2019-2030, $ mn 112 Table 31. UK Digital Biomarkers Market by System Component, 2019-2030, $ mn 114 Table 32. UK Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 114 Table 33. UK Digital Biomarkers Market by End User, 2019-2030, $ mn 114 Table 34. France Digital Biomarkers Market by System Component, 2019-2030, $ mn 116 Table 35. France Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 116 Table 36. France Digital Biomarkers Market by End User, 2019-2030, $ mn 116 Table 37. Netherlands Digital Biomarkers Market by System Component, 2019-2030, $ mn 118 Table 38. Netherlands Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 118 Table 39. Netherlands Digital Biomarkers Market by End User, 2019-2030, $ mn 118 Table 40. Italy Digital Biomarkers Market by System Component, 2019-2030, $ mn 120 Table 41. Italy Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 120 Table 42. Italy Digital Biomarkers Market by End User, 2019-2030, $ mn 120 Table 43. Russia Digital Biomarkers Market by System Component, 2019-2030, $ mn 122 Table 44. Russia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 122 Table 45. Russia Digital Biomarkers Market by End User, 2019-2030, $ mn 122 Table 46. Digital Biomarkers Market in Rest of Europe by Country, 2019-2030, $ mn 124 Table 47. APAC Digital Biomarkers Market by Country, 2019-2030, $ mn 127 Table 48. Japan Digital Biomarkers Market by System Component, 2019-2030, $ mn 131 Table 49. Japan Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 131 Table 50. Japan Digital Biomarkers Market by End User, 2019-2030, $ mn 131 Table 51. China Digital Biomarkers Market by System Component, 2019-2030, $ mn 133 Table 52. China Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 133 Table 53. China Digital Biomarkers Market by End User, 2019-2030, $ mn 133 Table 54. Australia Digital Biomarkers Market by System Component, 2019-2030, $ mn 135 Table 55. Australia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 135 Table 56. Australia Digital Biomarkers Market by End User, 2019-2030, $ mn 135 Table 57. India Digital Biomarkers Market by System Component, 2019-2030, $ mn 137 Table 58. India Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 137 Table 59. India Digital Biomarkers Market by End User, 2019-2030, $ mn 137 Table 60. South Korea Digital Biomarkers Market by System Component, 2019-2030, $ mn 139 Table 61. South Korea Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 139 Table 62. South Korea Digital Biomarkers Market by End User, 2019-2030, $ mn 139 Table 63. Digital Biomarkers Market in Rest of APAC by Country, 2019-2030, $ mn 141 Table 64. South America Digital Biomarkers Market by Country, 2019-2030, $ mn 144 Table 65. Argentina Digital Biomarkers Market by System Component, 2019-2030, $ mn 146 Table 66. Argentina Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 146 Table 67. Argentina Digital Biomarkers Market by End User, 2019-2030, $ mn 146 Table 68. Brazil Digital Biomarkers Market by System Component, 2019-2030, $ mn 148 Table 69. Brazil Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 148 Table 70. Brazil Digital Biomarkers Market by End User, 2019-2030, $ mn 148 Table 71. Chile Digital Biomarkers Market by System Component, 2019-2030, $ mn 150 Table 72. Chile Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 150 Table 73. Chile Digital Biomarkers Market by End User, 2019-2030, $ mn 150 Table 74. MEA Digital Biomarkers Market by Country, 2019-2030, $ mn 154 Table 75. UAE Digital Biomarkers Market by System Component, 2019-2030, $ mn 156 Table 76. UAE Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 156 Table 77. UAE Digital Biomarkers Market by End User, 2019-2030, $ mn 156 Table 78. Saudi Arabia Digital Biomarkers Market by System Component, 2019-2030, $ mn 158 Table 79. Saudi Arabia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 158 Table 80. Saudi Arabia Digital Biomarkers Market by End User, 2019-2030, $ mn 158 Table 81. Israel Digital Biomarkers Market by System Component, 2019-2030, $ mn 160 Table 82. Israel Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 160 Table 83. Israel Digital Biomarkers Market by End User, 2019-2030, $ mn 160 Table 84. Breakdown of Global Market by Key Vendor, 2019, % 164 Table 85. Actigraph LLC: Company Snapshot 167 Table 86. Actigraph LLC: Business Segmentation 167 Table 87. Actigraph LLC: Product Portfolio 168 Table 88. Actigraph LLC: Revenue, 2016-2018, $ mn 168 Table 89. Actigraph LLC: Recent Developments 168 Table 90. Risk Evaluation for Investing in Global Market, 2019-2030 197 Table 91. Critical Success Factors and Key Takeaways 200
List Of Figures
Figure 1. Research Method Flow Chart 14 Figure 2. Breakdown of Primary Research 16 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18 Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20 Figure 5. Global Digital Biomarkers Market, 2019-2030, $ mn 23 Figure 6. Category and Relationship of Traditional Biomarkers and Digital Biomarkers 24 Figure 7. Benefits and Challenges of Digital Biomarkers 26 Figure 8. Global Biomarkers Market, 2019-2030, $ mn 27 Figure 9. Share of Digital Biomarkers in Total Biomarkers Market, 2019-2030 27 Figure 10. Impact of COVID-19 on Business 28 Figure 11. Primary Drivers and Impact Factors of Global Digital Biomarkers Market 30 Figure 12. World 5G Traffic, 2019-2030, EB/year 33 Figure 13. Primary Restraints and Impact Factors of Global Digital Biomarkers Market 35 Figure 14. Data Security Risk in Various User Groups of Digital Biomarkers 38 Figure 15. Pathway to Regulatory Approval of Digital Biomarkers 39 Figure 16. Investment Opportunity Analysis 41 Figure 17. Porter’s Fiver Forces Analysis of Global Digital Biomarkers Market 44 Figure 18. Breakdown of Global Digital Biomarkers Market by System Component, 2019-2030, % of Revenue 49 Figure 19. Global Addressable Market Cap in 2020-2030 by System Component, Value ($ mn) and Share (%) 49 Figure 20. Global Digital Biomarkers Market: Data Collection Tools, 2019-2030, $ mn 50 Figure 21. Global Digital Biomarkers Market: Digital Platforms, 2019-2030, $ mn 52 Figure 22. Global Digital Biomarkers Market: Mobile Apps, 2019-2030, $ mn 53 Figure 23. Global Digital Biomarkers Market: Desktop-based Software, 2019-2030, $ mn 54 Figure 24. Global Digital Biomarkers Market: Wearables, 2019-2030, $ mn 55 Figure 25. Global Digital Biomarkers Market: Biosensors, 2019-2030, $ mn 56 Figure 26. Global Digital Biomarkers Market: Data Integration Systems, 2019-2030, $ mn 57 Figure 27. Breakdown of Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, % of Sales Revenue 59 Figure 28. Global Addressable Market Cap in 2020-2030 by Therapeutic Area, Value ($ mn) and Share (%) 59 Figure 29. Global Digital Biomarkers Market: Cardiovascular Diseases, 2019-2030, $ mn 60 Figure 30. Global Digital Biomarkers Market: Neurodegenerative Disorders, 2019-2030, $ mn 61 Figure 31. Global Digital Biomarkers Market: Parkinson’s Disease, 2019-2030, $ mn 63 Figure 32. Global Digital Biomarkers Market: Multiple Sclerosis, 2019-2030, $ mn 64 Figure 33. Global Digital Biomarkers Market: Alzheimer’s Disease, 2019-2030, $ mn 65 Figure 34. Global Digital Biomarkers Market: Sleep and Movement Diseases, 2019-2030, $ mn 66 Figure 35. Global Digital Biomarkers Market: Psychiatric Disorders, 2019-2030, $ mn 67 Figure 36. Global Digital Biomarkers Market: Chronic Pain, 2019-2030, $ mn 68 Figure 37. Global Digital Biomarkers Market: Gastrointestinal Diseases, 2019-2030, $ mn 69 Figure 38. Global Digital Biomarkers Market: Diabetes, 2019-2030, $ mn 70 Figure 39. Global Digital Biomarkers Market: Respiratory Conditions, 2019-2030, $ mn 71 Figure 40. Global Digital Biomarkers Market: Other Diseases, 2019-2030, $ mn 72 Figure 41. Breakdown of Global Digital Biomarkers Market by Application, 2019-2030, % of Sales Revenue 74 Figure 42. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 74 Figure 43. Global Digital Biomarkers Market: Wellness, 2019-2030, $ mn 75 Figure 44. Global Digital Biomarkers Market: Disease Diagnosis, 2019-2030, $ mn 76 Figure 45. Global Digital Biomarkers Market: Personalised Medication, 2019-2030, $ mn 77 Figure 46. Global Digital Biomarkers Market: Drug Discovery and Development, 2019-2030, $ mn 78 Figure 47. Classification of Digital Biomarkers by Development Status 80 Figure 48. Breakdown of Global Digital Biomarkers Market by Development Status, 2019-2030, % of Revenue 82 Figure 49. Global Addressable Market Cap in 2020-2030 by Development Status, Value ($ mn) and Share (%) 82 Figure 50. Global Digital Biomarkers Market: Novel Digital Biomarkers, 2019-2030, $ mn 83 Figure 51. Global Digital Biomarkers Market: Original Digital Biomarkers, 2019-2030, $ mn 84 Figure 52. Global Digital Biomarkers Market: Approved Digital Biomarkers, 2019-2030, $ mn 85 Figure 53. Breakdown of Global Digital Biomarkers Market by End User, 2019-2030, % of Revenue 87 Figure 54. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 87 Figure 55. Global Digital Biomarkers Market: Biopharmaceutical Companies & Labs, 2019-2030, $ mn 88 Figure 56. Global Digital Biomarkers Market: Healthcare Providers, 2019-2030, $ mn 89 Figure 57. Global Digital Biomarkers Market: Insurance Payers, 2019-2030, $ mn 90 Figure 58. Global Market Snapshot by Region 91 Figure 59. Geographic Spread of Worldwide Digital Biomarkers Market, 2019-2030, % of Sales Revenue 92 Figure 60. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 93 Figure 61. North American Digital Biomarkers Market, 2019-2030, $ mn 96 Figure 62. Breakdown of North America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 97 Figure 63. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 98 Figure 64. U.S. Digital Biomarkers Market, 2019-2030, $ mn 100 Figure 65. Canada Digital Biomarkers Market, 2019-2030, $ mn 103 Figure 66. Digital Biomarkers Market in Mexico, 2015-2030, $ mn 105 Figure 67. European Digital Biomarkers Market, 2019-2030, $ mn 108 Figure 68. Breakdown of European Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 109 Figure 69. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 110 Figure 70. Digital Biomarkers Market in Germany, 2019-2030, $ mn 111 Figure 71. Digital Biomarkers Market in UK, 2019-2030, $ mn 113 Figure 72. Digital Biomarkers Market in France, 2019-2030, $ mn 115 Figure 73. Digital Biomarkers Market in Netherlands, 2019-2030, $ mn 117 Figure 74. Digital Biomarkers Market in Italy, 2019-2030, $ mn 119 Figure 75. Digital Biomarkers Market in Russia, 2019-2030, $ mn 121 Figure 76. Digital Biomarkers Market in Rest of Europe, 2019-2030, $ mn 123 Figure 77. Asia-Pacific Digital Biomarkers Market, 2019-2030, $ mn 126 Figure 78. Breakdown of APAC Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 126 Figure 79. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 128 Figure 80. Digital Biomarkers Market in Japan, 2019-2030, $ mn 130 Figure 81. Digital Biomarkers Market in China, 2019-2030, $ mn 132 Figure 82. Digital Biomarkers Market in Australia, 2019-2030, $ mn 134 Figure 83. Digital Biomarkers Market in India, 2019-2030, $ mn 136 Figure 84. Digital Biomarkers Market in South Korea, 2019-2030, $ mn 138 Figure 85. Digital Biomarkers Market in Rest of APAC, 2019-2030, $ mn 140 Figure 86. South America Digital Biomarkers Market, 2019-2030, $ mn 143 Figure 87. Breakdown of South America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 143 Figure 88. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 144 Figure 89. Digital Biomarkers Market in Argentina, 2019-2030, $ mn 145 Figure 90. Digital Biomarkers Market in Brazil, 2019-2030, $ mn 147 Figure 91. Digital Biomarkers Market in Chile, 2019-2030, $ mn 149 Figure 92. Digital Biomarkers Market in Rest of South America, 2019-2030, $ mn 151 Figure 93. Digital Biomarkers Market in Middle East and Africa (MEA), 2019-2030, $ mn 153 Figure 94. Breakdown of MEA Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 153 Figure 95. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 154 Figure 96. Digital Biomarkers Market in UAE, 2019-2030, $ mn 155 Figure 97. Digital Biomarkers Market in Saudi Arabia, 2019-2030, $ mn 157 Figure 98. Digital Biomarkers Market in Israel, 2019-2030, $ mn 159 Figure 99. Growth Stage of Global Digital Biomarkers Industry over the Forecast Period 162
Key Players (this may not be a complete list and extra companies can be added upon request): Actigraph LLC Akili Interactive Labs AliveCor Inc Altoida Inc Amgen Inc Bayer AG Biogen Inc Cambridge Cognition Plc Eli Lilly and Company Evidation Health, Inc. F. Hoffmann-La Roche Ltd Fitbit Inc GlaxoSmithKline Plc Happify Health Human API IXICO Plc Koninklijke Philips N.V. Medical Care Corporation Medopad Ltd Mindstrong Health Neurotrack Technology, Inc Novartis International AG Pfizer Inc. Quanterix Corporation Sanofi S.A. The Takeda Pharmaceuticals Company Limited Verily Life Sciences Winterlight Labs Inc.